SCHEMBL5958331

SCHEMBL5958331

CCCOC12CCCCC1O2

nearest known ligand 0.31

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 2/20 0.31
SLC6A4 P31645 2/20 0.31
OPRM1 P35372 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9133434 0.85
SCHEMBL5675346 0.74
SCHEMBL8645184 0.73 TP53 (0.36)
SCHEMBL11584582 0.70
SCHEMBL5608046 0.70 CYP2C19 (0.33) OPRM1
SCHEMBL2128532 0.68 OPRM1 (0.36) OPRM1
1,4-Butanediol SCHEMBL11761054 0.67 CYP4F2 (0.31)
SCHEMBL7600518 0.67 EP300 (0.31)
SCHEMBL5697820 0.66
SCHEMBL13740855 0.65 CYP2C19 (0.30)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060105047-A1 Novel prepolymers useful in biomedical devices BAUSCH & LOMB INCORPORATED (US) 2006-05-18 US disclosed
US-20050100579-A1 Novel prepolymers useful in biomedical devices BAUSCH & LOMB INCORPORATED (US) 2005-05-12 US disclosed
US-6858218-B2 Hydrogel from polysiloxane-containing urethane prepolymer, tris (trimethylsiloxy) silylpropyl methacrylate, and a hydrophilic comonomer BAUSCH & LOMB INCORPORATED (US) 2005-02-22 US disclosed
US-20030157141-A1 Novel prepolymers useful in biomedical devices BAUSCH & LOMB INCORPORATED (US) 2003-08-21 US disclosed
US-6596294-B2 Oxygen permeability and superior physical properties, contact lenses BAUSCH & LOMB INCORPORATED 2003-07-22 US disclosed
US-20020037271-A1 Novel prepolymers useful in biomedical devices BAUSCH & LOMB INCORPORATED 2002-03-28 US disclosed
US-6312706-B1 ACRYLIC POLYMERS, COPOLYMERS AND POLYSILOXANE URETHANES BAUSCH & LOMB INCORPORATED 2001-11-06 US disclosed
CN-1056626-C Method for preparing surface active random copolymer BAUSCH & LOMB (US) 2000-09-20 CN disclosed
CN-1048265-C Surface modification of polymer objects BAUSCH & LOMB (US) 2000-01-12 CN disclosed
CN-1048021-C Process for preparing surface active macromonomers BAUSCH & LOMB (US) 2000-01-05 CN disclosed
US-5135297-A Immersing a contact lens in an aqueous dispersion of a polymerizable surfactant macromer, a crosslinker and a free radical catalyst and irradiating with UV light; wetting agents BAUSCH & LOMB INCORPORATED (US) 1992-08-04 US disclosed
US-5128434-A Contact lenses BAUSCH & LOMB INCORPORATED (US) 1992-07-07 US disclosed
CN-1061980-A The control of hard segment size in the urethane forming process BAUSCH & LOMB (US) 1992-06-17 CN disclosed
CN-1061978-A Surface active macromonomers BAUSCH & LOMB (US) 1992-06-17 CN disclosed
WO-1992009639-A2 SURFACE-ACTIVE MACROMONOMERS BAUSCH & LOMB INCORPORATED (US) 1992-06-11 WO disclosed
WO-1992009650-A1 SURFACE COATING OF POLYMER OBJECTS BAUSCH & LOMB INCORPORATED (US) 1992-06-11 WO disclosed
WO-1992009644-A1 SURFACE MODIFICATION OF POLYMER OBJECTS BAUSCH & LOMB INCORPORATED (US) 1992-06-11 WO disclosed
CN-1061785-A The surface modification of polymer articles BAUSCH & LOMB (US) 1992-06-10 CN disclosed
CN-1061786-A The surface coated of polymer articles BAUSCH & LOMB (US) 1992-06-10 CN disclosed
EP-0401990-A2 Prepolymers useful in biomedical devices BAUSCH & LOMB INCORPORATED (US) 1990-12-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020037271-A1 Novel prepolymers useful in biomedical devices TMEM63A, ECPAS, COL2A1 SLC6A2 3838/4885SLC6A4 4309/4885OPRM1 1609/4885
US-20060105047-A1 Novel prepolymers useful in biomedical devices TMEM63A, ECPAS, COL2A1 SLC6A2 3838/4885SLC6A4 4309/4885OPRM1 1609/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.